Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis

Iranian Journal of Kidney Diseases

Volumn 3, Issue 1, 2009, Pages 22-27

  Ahmadpoor, Pedram ^a   Eftekhar, Ebrahim ^b   Nourooz Zadeh, Jafar ^b   Servat, Hossien ^b   Makhdoomi, Khadijeh ^b   Ghafari, Ali ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; Glutathione; Glutathione peroxidase; Glutathione reductase; Hemodialysis; Oxidative stress; Peritoneal dialysis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; FEMALE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MALE; OXIDATIVE STRESS; PROTEIN DEPLETION;

ADULT; AGED; ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS;

EID: 64549144708     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32:S112-9.
2. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000;356:147-52.
3. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58:353-62.
4. Himmelfarb J. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Semin Dial. 2004;17:449-54.
5. Zalba G, Fortuno A, Diez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrol Dial Transplant. 2006;21:2686-90.
6. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol. 2004;24:469-73.
7. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta. 2003;333:19-39.
8. Santangelo F, Witko-Sarsat V, Drueke T, Descamps-Latscha B. Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrol Dial Transplant. 2004;19:1951-5.
9. Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial. Circulation. 2003;107:992-5.
10. Zachara BA, Gromadzinska J, Wasowicz W, Zbrog Z. Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review. Acta Biochim Pol. 2006;53:663-77.
11. Ross EA, Koo LC, Moberly JB. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1997;30:489-94.
12. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant. 1997;12:2312-7.
13. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502-22.
14. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-69.
15. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985;113:484-90.
16. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239:70-6.
17. Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem. 2002;35:269-73.
18. Hemmati M, Kadkhodaee, Zahmatkesh M, Mahdavi-Mazdeh M, Ghaznavi R, Mirershadi F. Blood antioxidant levels and alterations of serum calcium and pH in hemodialysis patients. Tehran Univ Med J. 2008;66:12-7.
19. Durak I, Akyol O, Basesme E, Canbolat O, Kavutcu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron. 1994;66:76-80.
20. Pasaoglu H, Muhtaroglu S, Gunes M, Utas C. The role of the oxidative state of glutathione and glutathione-related enzymes in anemia of hemodialysis patients. Clin Biochem. 1996;29:567-72.
21. Alhamdani MS. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Nephrol Dial Transplant. 2005;20:124-8.
22. Yoshimura S, Suemizu H, Nomoto Y, et al. Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron. 1996;73:207-11.
23. Roxborough HE, Mercer C, McMaster D, Maxwell AP, Young IS. Plasma glutathione peroxidase activity is reduced in haemodialysis patients. Nephron. 1999;81:278-83.
24. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med. 1996;21:845-53.
25. Zachara BA, Salak A, Koterska D, Manitius J, Wasowicz W. Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol. 2004;17:291-9.
26. Yamamoto Y, Takahashi K. Glutathione peroxidase isolated from plasma reduces phospholipid hydroperoxides. Arch Biochem Biophys. 1993;305:541-5.
27. McGrath LT, Douglas AF, McClean E, et al. Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis. Clin Chim Acta. 1995;235:179-88.
28. Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta. 1987;924:408-19.
29. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem. 1995;41:1135-8.
30. Wayner DD, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett. 1985;187:33-7.
31. Habif S, Mutaf I, Turgan N, et al. Age and gender dependent alterations in the activities of glutathione related enzymes in healthy subjects. Clin Biochem. 2001;34:667-71.
32. Samadian F, Lessan-Pezeshki M, Mahdavi-Mazdeh M, Kadkhodaie M, Seifi S, Ahmadi F. Relation of antioxidants and acute-phase reactants in patients receiving hemodialysis. Iran J Kidney Dis. 2007;1:38-42.